D007 Acute Lymphoblastic Leukemia: The New Addition to the digitalMLPA Assay Portfolio
We are pleased to announce the launch of our second SALSA® digitalMLPA™ panel: SALSA digitalMLPA Probemix D007 Acute Lymphoblastic Leukemia. Acute Lymphoblastic Leukemia (ALL) leukemia is a blood cancer known for its genetic complexity. Identifying the genotypic signatures of ALL’s various subtypes is useful in predicting disease outcome.
The panel targets 55 genes and regions that play a role in ALL, including IKZF1, iAMP21, ERG, and many more. In addition, the panel covers most chromosomal arms, thus allowing for the detection of gross copy number alterations and ploidy status.
The D007 Acute Lymphoblastic Leukemia assay combines the confidence in CNV calling of the trusted MLPA technology with the extensive coverage of next generation sequencing.
Download D007 Acute Lymphoblastic Leukemia product flyer
This assay is for Research Use Only (RUO). Not for use in diagnostic procedures.